Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Evotec Partnered With Genentech

May 10, 2010 7:56 am | News | Comments

Evotec AG announced that it has entered into a multi-year integrated drug discovery alliance with Genentech Inc., a wholly owned member of the Roche Group, to discover novel small molecule therapeutics.


ADDF Awards Grant to Amicus Therapeutics

May 10, 2010 7:50 am | News | Comments

The Alzheimer’s Drug Discovery Foundation (ADDF) has awarded a grant of $210,300 to Amicus Therapeutics to evaluate small-molecule, orally delivered pharmacological chaperone compounds as a novel approach for treating Alzheimer’s disease.


Canadian Scientists Develop Mouse Grimace Scale

May 10, 2010 7:43 am | News | Comments

A new study by researchers from McGill University and the University of British Columbia shows that mice, like humans, express pain through facial expressions.


Scripps Researchers Find Key to Gaucher Treatment

May 10, 2010 7:37 am | News | Comments

In findings that advance scientists' understanding of a whole class of inherited disorders, The Scripps Research Institute has shed light on a mechanism that enables a potential treatment for Gaucher's disease and other lysosomal storage diseases.


Pramipexole Improves Mood in Parkinson's Patients

May 10, 2010 7:31 am | News | Comments

Pramipexole, a dopamine agonist, improves depressive symptoms in patients with Parkinson's disease (PD), and has the potential to become an important antidepressant treatment for these patients.


Phase 2 VB-201 Trial Successful

May 10, 2010 7:22 am | News | Comments

VBL Therapeutics announced positive preclinical results evaluating VB-201 for the treatment of psoriasis. VB-201 is a first-in-class, orally administered immune response modifier expected to reduce inflammation by targeting key pro-inflammatory cytokines.


SBS And ALA to Merge

May 10, 2010 7:18 am | News | Comments

Members of both SBS and ALA showed overwhelming support for uniting as Sections within the new inclusive organization -- the Society for Laboratory Automation and Screening.


miR-155 Can Inhibit Cancer Protective Genes

May 10, 2010 7:04 am | News | Comments

New research shows for the first time that molecules called microRNA can silence genes that protect the genome from cancer-causing mutations.


Scientists Discover Bacteria-Tumor Link

May 10, 2010 6:53 am | News | Comments

A team of University of California, San Diego School of Medicine researchers has discovered that common intestinal bacteria appear to promote tumor growths in genetically susceptible mice, but that tumorigenesis can be suppressed if the mice are exposed to an inhibiting protein enzyme.


Collaborations Leading to Cheaper Drugs in Developing Countries

May 10, 2010 6:40 am | News | Comments

The availability of more affordable drugs, vaccines and diagnostics that would help countless people worldwide is the foremost benefit expected from a growing number of collaborations between biotech firms in developing countries.


Teva And Baxter Ordered to Pay $500M In Damages

May 10, 2010 6:37 am | by Oskar Garcia | News | Comments

A jury in Las Vegas ordered two drug companies to pay a combined $500 million in punitive damages in the first of hundreds of civil cases stemming from a hepatitis C outbreak two years ago.


President Claims Health Care Bill Helping Millions

May 10, 2010 6:32 am | by Charles Babington | News | Comments

On June 15, some older people with high prescription drug costs will receive $250 to help fill a gap in Medicare's pharmaceutical benefits.


Cancer Costs Double Over Past Two Decades

May 10, 2010 6:21 am | News | Comments

The cost of treating cancer in the United States nearly doubled over the past two decades, but expensive cancer drugs may not be the main reason why, according to a surprising new study.


Data Analysis Software

May 7, 2010 7:55 am | Product Releases | Comments

Strand Life Sciences has entered into an agreement with the FDA to deliver the Genomics Reviewer Desktop (GRD), a solution to enable FDA reviewers to manage and analyze pharmacogenomic data submitted through its Voluntary Exploratory Data Submissions (VXDS) program.


Analyte Detector

May 7, 2010 7:40 am | Product Releases | Comments

Available from Dorton Analytical the ultra-sensitive, universal Nano Quantity Analyte Detector (NQAD) presents a major advancement in high performance liquid chromatography detection capability.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.